Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy · Major Depressive Disorder · Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Wells Medicine, Houston, Texas, United States
Contact: Study coordinator (Jesse Wells) · mail@wellsmedicine.com · (713) 589-5118
Texas A&M (Houston Methodist Hospital Location), Houston, Texas, United States
Contact: Study coordinator (Nicholas Murphy) · nicholas.murphy@bcm.edu · 713-798-7593
Contact: Study coordinator (Sanjay Mathew) · sjmathew@bcm.edu · 7137985877

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

Healthy · Hepatic Impairment

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Houston, United States

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Ruddington, United Kingdom

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

C3 Glomerulopathy (C3G) · Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Vienna, Austria · Brussels, Belgium